Monivent names Tobias Tullberg CEO, effective Jan. 4, 2027

PUBT · 1d ago
Monivent names Tobias Tullberg CEO, effective Jan. 4, 2027
  • Monivent named Tobias Tullberg CEO effective Jan. 4, 2027, as it shifts toward commercialization and international expansion.
  • Tullberg was CEO of AprioMed since 2011, leading growth and international expansion through its sale to IZI Medical.
  • Founder Maria Lindqvist will move from CEO to a new role focused on product development and clinical collaborations when Tullberg starts.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monivent AB published the original content used to generate this news brief via Cision (Ref. ID: 202609041230BITN____UKPR__SV_20260904-BIT-6597-0) on September 04, 2026, and is solely responsible for the information contained therein.